← SynDRA
SJG-136
SynDRA canonical compound SYN0000991 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CASP3 |
|---|
| Mechanism of action | DNA intercalating agent |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- BN-2629
- NSC-694501
- SG-2000
- SP-2001
- UP-2001
- Sjg 136
- NSC 694501
- KT0ZQ64X1A
- UP 2001
- SJG136
- RefChem:931818
- DTXCID80100355
- UNII-KT0ZQ64X1A
- MFCD19443671
- NSC694501
- orb1706628
- SCHEMBL12020905
- SCHEMBL29470580
- SJG 136 [WHO-DD]
- C31H32N4O6
- EX-A9464
- AKOS027326601
- CS-4593
- BP-43616
- BS-42683
- DA-77868
- HY-14573
- NCI60_033825
- NS00069744
- C74198
- T16890
Look up SJG-136 in the interactive SynDRA portal →